Side Effects of Male Cancers - Better Survival and Growing Social Acceptance of Impotence and Urinary Incontinence Equates to New Opportunities for Drug Therapies
Datamonitor, Feb 2002
This brief provides a survey and summary analysis of the commercially significant side effects of male cancers and their treatment. The brief will prove most useful to pharmaceutical companies interested in opportunities for increased commercialization of drug therapy for managing male cancer side effects, and for closing the considerable gap in support for the side effects of male cancers (overall) versus female cancers such as breast and ovarian malignancies.Estimates of the prevalence of male cancers across the major markets, 2001-2010Review and clinical analysis of the medical literature addressing male cancers side effects including impotence and incontinenceAnalysis of the commercialization potential present in the context of these side effects within the male cancers populationProstate cancer is associated with the greatest unmet needs in terms of side effects for male cancers and their treatment.Pharmacological approaches to erectile dysfunction offer the greatest commercial potential in addressing unmet needs associated with male cancer side effects.There is a clinical and commercial gap between pharmaceutical approaches to managing the side effects of female cancers and those used for male cancers. Closing this gap would translate into considerable commercial gain.Understand the prevalence of cancer-associated impotence and other side effects, and assess the level of opportunity for pharmaceutical responsesGrasp the present and emerging commercial dynamic among current and pipeline products for male cancers side effects.Identify the potential for therapeutic control of side effects, and formulate strategies for using oncology as a platform for broader launch.
